Cigna Group (NYSE:CI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cigna Group (NYSE:CIFree Report) from a hold rating to a buy rating in a report released on Sunday morning.

Several other brokerages have also recently weighed in on CI. Barclays decreased their price target on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research note on Friday, October 31st. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Truist Financial dropped their target price on Cigna Group from $375.00 to $310.00 in a report on Friday, October 31st. Cantor Fitzgerald decreased their price target on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. Finally, JPMorgan Chase & Co. dropped their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $331.83.

Get Our Latest Stock Report on Cigna Group

Cigna Group Trading Up 0.1%

NYSE:CI opened at $276.36 on Friday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The firm has a market cap of $73.82 billion, a PE ratio of 12.19, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a fifty day moving average price of $274.01 and a 200 day moving average price of $290.71.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were paid a dividend of $1.51 per share. The ex-dividend date was Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.64%.

Insider Activity

In related news, CEO David Cordani bought 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This trade represents a 9.49% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of institutional investors and hedge funds have recently made changes to their positions in CI. Harbor Capital Advisors Inc. boosted its holdings in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares in the last quarter. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group during the 1st quarter valued at approximately $28,000. 1248 Management LLC acquired a new stake in shares of Cigna Group during the 1st quarter valued at approximately $29,000. Solstein Capital LLC purchased a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Finally, Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.